SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

31 Oct 2023 07:00

RNS Number : 7845R
TP ICAP Group plc
31 October 2023
Β 

TP ICAP GROUP PLC ("TP ICAP" or the "Group")

Β 

31 October 2023

Β 

Β 

Trading update for the nine months ended 30 September 2023

Β 

Β 

Year-to-date performance (in constant currency, unless in brackets, which denotes reported currency)

Β 

Total Group revenue of Β£1,644m up 2% (+4% in reported currency). The Group in particular benefited from buoyant energy market conditions, with Energy & Commodities (E&C) leveraging its market-leading position across all the main asset classes.

At the divisional level, as expected, Global Broking (GB) revenue was down 1% (unchanged in reported currency), as the exceptional, volatility-driven volumes seen in 2022 did not re-occur in the first nine months of this year. In E&C, revenue was up 16% (+19%), with significant growth across the board.

Liquidnet division revenue was down 3% (-1%). There was a strong performance from the Relative Value business; Equities declined in line with subdued block market activity. Liquidnet's Dealer-to-Client Credit proposition progressing.

Β 

Parameta Solutions revenue was up 5% (+8%).

Β 

The Group continues to trade in line with the Board's expectations.

Β 

Third quarter performance: 1 July to 30 September 2023 (in constant currency, unless in brackets, which denotes reported currency)

Β 

Total Group revenue was Β£512m, up 5% (+1%).

Β 

GB revenue was down 2% (-6%), following a 12% increase in the revenue base for the same period last year. E&C revenue growth accelerated - up 28% (+22%) - reflecting the positive market developments, and the division's strong position.

Β 

Liquidnet's revenue increased by 6% (+3%). Growth in Equities more than offset a decline in the non-platform business.

Β 

Parameta Solutions revenue was up 7% (+2%).

Β 

Β 

2023 preliminary results

Β 

The Group will report its 2023 preliminary results on 12 March 2024.Β 

Β 

Β 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

Β 

Enquiries:

Group Company Secretary Vicky Hart Email: companysecretarial@tpicap.com

Β 

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com Β 

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

Β Β 

About TP ICAP

Β· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

Β· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

Β· We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

Β 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFFFEFIVLIVIV
Date   Source Headline
5th Jan 20172:13 pmRNSHolding(s) in Company
4th Jan 201711:38 amRNSHolding(s) in Company
3rd Jan 20175:51 pmRNSTotal Voting Rights
30th Dec 20168:05 amRNSAdmission of new shares
30th Dec 20167:00 amRNSCompletion of transaction with NEX
28th Dec 201611:07 amRNSChange of Name
28th Dec 20167:00 amRNSStatement re transaction with NEX
9th Dec 20167:00 amRNSDividend Declaration
6th Dec 20161:40 pmRNSStatement re transaction with ICAP
1st Dec 201610:02 amRNSHolding(s) in Company
23rd Nov 201611:29 amRNSHolding(s) in Company
15th Nov 201612:09 pmRNSStatement re transaction with ICAP
4th Nov 20167:00 amRNSTrading Statement
1st Nov 201612:52 pmRNSDirector Declaration
3rd Oct 20162:34 pmRNSTP ICAP Global Executive Committee
3rd Oct 20162:29 pmRNSTullett Prebon Management Changes
3rd Oct 20169:55 amRNSTotal Voting Rights
27th Sep 20162:15 pmRNSAdditional Listing
26th Sep 20167:03 amRNSStatement re transaction with ICAP
12th Sep 20163:49 pmRNSPublication of Supplementary Prospectus
8th Sep 201612:20 pmRNSStatement on transaction with Tullett Prebon
8th Sep 201612:15 pmRNSStatement re transaction with ICAP
24th Aug 20162:15 pmRNSHolding(s) in Company
3rd Aug 20162:15 pmRNSDirector/PDMR Shareholding
2nd Aug 20169:08 amRNSNew Technology Centre, Belfast Northern Ireland
2nd Aug 20167:00 amRNSHalf-year Report
22nd Jul 20161:15 pmRNSStatement re transaction with ICAP
29th Jun 20166:00 pmRNSNotification of Interim Results
21st Jun 20166:25 pmRNSStatement re transaction with ICAP
20th Jun 201610:21 amRNSHolding(s) in Company
7th Jun 20167:09 amRNSStatement re. CMA announcement
6th Jun 20164:18 pmRNSHolding(s) in Company
16th May 201612:08 pmRNSPublication of Supplementary Prospectus
16th May 20167:13 amRNSIGBB FY 2016 results
13th May 201612:16 pmRNSDirectorate Change
13th May 201610:17 amRNSResult of AGM
12th May 20167:00 amRNSTrading Statement
6th May 20167:00 amRNSDirectorate Change
5th May 20164:41 pmRNSDirector/PDMR Shareholding
4th May 201612:51 pmRNSHolding(s) in Company
22nd Apr 20165:18 pmRNSDirector/PDMR Shareholding
19th Apr 20165:27 pmRNSDirector/PDMR Shareholding
5th Apr 20162:49 pmRNSPublication of Supplementary Prospectus
4th Apr 20164:48 pmRNSAnnual Financial Report
24th Mar 20162:16 pmRNSEGM Statement
1st Mar 201611:37 amRNSPublication of Prospectus
1st Mar 20167:00 amRNSFinal Results
1st Mar 20167:00 amRNSStatement re acquisition
5th Feb 20168:00 amRNSAdoption of Financial Reporting Standard (FRS)101
2nd Feb 20167:00 amRNSStatement re acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.